Lenvatinib versus Sorafenib as first‐line treatment in hepatocellular carcinoma: A multi‐institutional matched case‐control studyMargherita Rimini, Andrea Casadei‐Gardini, Gianluca Masi et al.|Hepatology Research|2021Cited by 46
Identification of lenvatinib prognostic index via recursive partitioning analysis in advanced hepatocellular carcinomaIlario Giovanni Rapposelli, Andrea Casadei‐Gardini, Shigeo Shimose et al.|ESMO Open|2021Cited by 20